Genomic Medicine in Resource-limited Countries: Genomics for Every Nation provides in-depth analysis and key examples of the implementation of medical genomics in low-income nations across the globe, demonstrating how this advancing medical science has not only transformed health systems, but also led to improved patient care in Indonesian, Nepalese, Chilean, Malaysian, Tanzanian, Argentinian, Chinese, Sri Lankan and Columbian populations, among others. In addition to defining tools, diagnostics and treatment pathways at the population-wide level for medical geneticists, genomic researchers and public health workers, this book offers a case-study based approach that helps users understand how genomic medicine is used in disease-management.
- Examines essential concepts and protocols, and economic, social and legal considerations related to the implementation of genomic medicine in resource-limited nations
- Features concrete success stories of the implementation of medical genomics in Indonesian, Nepalese, Chilean, Malaysian, Tanzanian, Argentinian, Chinese, Sri Lankan and Columbian populations, amongst others
- Provides tools, diagnostics and treatment pathways for medical geneticists, genomic researchers and public health workers to apply in their own work
- Establishes clear precedents on how genomic technologies can be accessed by nations with limited means and financial support for healthcare
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
2. Building internationally renewed biobanks in resource limited countries
3. Taking Genomics from the bench to the bed in a developing country
4. Genotyping at a population level
5. Screening for hereditary cancer in Chile
6. Genomic Medicine in Korea
7. Implementing Medical Genomics in China
8. A success story of the use of genomics in Malaysia
9. Creating a genomics company in India
10. Combating sickle cell disease with genomics in Tanzania
11. Implementing genomics in the care of neuropsychiatric patients in Latin America
12. Creating a Personalized Medicine Company in Argentina
13. Measuring the economic and social impact of genomics in developing countries
14. A global effort to spearhead implementation of genomics into healthcare for developing nations
Dr. George Patrinos is an Associate Professor at the University of Patras School of Health Sciences (Department of Pharmacy) in Patras, Greece with Adjunct positions in Rotterdam, the Netherlands and Al-Ain, United Arab Emirates. His research interests span the fields of molecular diagnostics, high-throughput mutation screening, the development of online mutation diagnostic tools, and the implementation of genomics into healthcare, particularly for health systems in developing countries. George Patrinos has published more than 170 scientific papers in peer reviewed journals on topics related to genetics, genomic medicine, pharmacogenomics, molecular diagnostics, and social and economic evaluation for genomic medicine. Dr. Patrinos is also the co-author of Economic Evaluation in Genomic Medicine (2015) and co-Editor of Molecular Diagnostics, Second Edition (2009), both published by Elsevier, and serves as Communicating Editor for the journal Human Mutation. Additionally, he is co-organizer of the international meeting series "Golden Helix Symposia and "Golden Helix Pharmacogenomics Days.
Dr. Catalina Lopez-Correa is Vice-President and CSO of Genome British Columbia, an organization that leads genomic innovation in British Columbia and facilitates the integration of genomics into society. She has more than 18 years of experience in the field of genomics, particularly in the use of genomic technologies to ensure economic and social impact in resource-limited nations, and the implementation of genomic technologies into health care systems. She has participated in several international initiatives on the implementation of genomics and is scientific advisor to the company BioGenomas which offers genetic testing services in Colombia. Since 2002, Dr. Lopez-Correa has also served as evaluator for large multinational projects funded by the European Commission, the IMI (Innovative Medicines Initiatives) and the NIH and has been recognized by several awards nationally and internationally. As part of her commitment to international development, Dr. Lopez-Correa funded the not-for-profit organization ODNS (Organisation pour le Développement avec des Nouvelles Solidarités) in 2012 and has been involved in several initiatives aimed at demonstrating the impact of genomics in developing countries. Dr. Lopez-Correa has published 9 scientific papers in peer reviewed journals on topics ranging from human genomics to genomic medicine implementation and molecular pathology.